{
    "clinical_study": {
        "@rank": "80684", 
        "arm_group": [
            {
                "arm_group_label": "Magnesium sulphate", 
                "arm_group_type": "Active Comparator", 
                "description": "The patients in this group underwent general anaesthesia with total intravenous anesthesia containing Remifentanyl (0,3 mg/kg ideal body weight/h), Propofol (4 mg/kg ideal body weight/h) and Atracurium.\nThey also received 40mg/kg ideal body weight magnesium sulphate by bolus injection before the operation started, followed by a continuous application of 10mg/kg ideal body weight/hour for 24 hours."
            }, 
            {
                "arm_group_label": "No treatment", 
                "arm_group_type": "No Intervention", 
                "description": "The patients in this group underwent general anaesthesia with total intravenous anesthesia containing Remifentanyl (0,3 mg/kg ideal body weight/h), Propofol (4 mg/kg ideal body weight/h) and Atracurium. They received no additional medication."
            }
        ], 
        "brief_summary": {
            "textblock": "Atrial fibrillation and chronic neuropathic pain are adverse events occurring after\n      posterolateral thoracotomy for lung resection. The continuous application of magnesium\n      sulphate may have a prophylactic effect. The investigators record the incidence of atrial\n      fibrillation during a seven day period after thoracotomy as well as the incidence of chronic\n      neuropathic pain during a three months period, comparing one group with a continuous\n      application of magnesium sulphate against one group without magnesium sulphate."
        }, 
        "brief_title": "Atrial Fibrillation and Neuropathic Pain After Thoracotomy and Continuous Application of Magnesium Sulphate.", 
        "completion_date": {
            "#text": "May 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Atrial Fibrillation", 
            "Neuropathic Pain"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Atrial Fibrillation", 
                "Neuralgia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years or older\n\n          -  posterolateral thoracotomy for lung parenchyma resection\n\n          -  informed consent\n\n        Exclusion Criteria:\n\n          -  hypersensitivity for magnesium sulphate\n\n          -  pre-existing atrial fibrillation\n\n          -  participation in another trial\n\n          -  pregnancy or breastfeeding"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02008747", 
            "org_study_id": "HSK 002"
        }, 
        "intervention": {
            "arm_group_label": "Magnesium sulphate", 
            "description": "Continuous application of magnesium sulphate applied 40 mg/kg ideal body weight by bolus before the operation started, followed by a continuous infusion of 10 mg/kg ideal body weight/h for 24 hours", 
            "intervention_name": "Magnesium sulphate", 
            "intervention_type": "Drug", 
            "other_name": "Mg 5 Sulfat 10%"
        }, 
        "intervention_browse": {
            "mesh_term": "Magnesium Sulfate"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Atrial fibrillation", 
            "Neuropathic pain", 
            "Posterolateral thoracotomy", 
            "Lung resection"
        ], 
        "lastchanged_date": "December 7, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Wiesbaden", 
                    "country": "Germany", 
                    "zip": "65199"
                }, 
                "name": "HSK"
            }
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effects of Prophylactic Administration of Magnesium Sulfate on the Incidence of Atrial Fibrillation and Chronic Neuropathic Pain After Thoracotomy for Lung Resection.", 
        "other_outcome": {
            "description": "The incidence of hypotonia during the time of continuous magnesium sulphate application was recorded.", 
            "measure": "Hypotonia", 
            "safety_issue": "No", 
            "time_frame": "24 hours perioperative"
        }, 
        "overall_official": {
            "affiliation": "HSK Wiesbaden", 
            "last_name": "Grietje Beck, Prof.", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The incidence of atrial fibrillation was recorded using a 12 lead ECG for a period of 7 days after operation", 
            "measure": "Incidence of atrial fibrillation", 
            "safety_issue": "No", 
            "time_frame": "Up to 168 hours after operation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02008747"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The incidence of neuropathic pain was recorded using the LANSS Score during a period of three months after posterolateral thoracotomy for lung resection.", 
            "measure": "Chronic neuropathic pain", 
            "safety_issue": "No", 
            "time_frame": "Three months"
        }, 
        "source": "Dr. Horst Schmidt Klinik GmbH", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Horst Schmidt Klinik GmbH", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}